Identification of phytomolecules as isoform and mutation specific PI3K-α inhibitor for protection against breast cancer using e-pharmacophore modeling and molecular dynamics simulations
2024

Natural Compounds as PI3K-α Inhibitors for Breast Cancer

Sample size: 7 publication Evidence: moderate

Author Information

Author(s): Mili Ajay, Birangal Sumit, Giridhar Jyothi, Nandakumar Krishnadas, Lobo Richard

Primary Institution: Manipal Academy of Higher Education, Manipal

Hypothesis

The research aimed to identify natural compounds that can inhibit mutant and specific isoforms of PI3K-α to prevent tumor progression.

Conclusion

Three natural compounds were identified as promising PI3K-α inhibitors, showing potential for breast cancer treatment with fewer side effects than conventional medicines.

Supporting Evidence

  • PI3K-α mutation is responsible for about 29% of breast cancers.
  • Natural products have shown potential in targeting multiple pathways involved in cancer progression.
  • Three compounds demonstrated significant stability and interaction with PI3K-α in molecular dynamics simulations.

Takeaway

Scientists found some natural substances that might help stop a type of breast cancer by blocking a specific protein that helps tumors grow.

Methodology

The study used e-pharmacophore modeling, molecular docking, and molecular dynamics simulations to identify and evaluate natural compounds as PI3K-α inhibitors.

Limitations

The study's findings need validation through proper in vivo and in vitro models.

Digital Object Identifier (DOI)

10.1186/s13065-024-01317-w

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication